Education
About Us
Working with TipRanks
Follow Us
Vivani Medical (VANI)
NASDAQ:VANI
VANI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.00 - $2.22
Previous CloseN/A
Volume36.09K
Average Volume (3M)93.93K
Market Cap
$62.20M
Enterprise Value$67.81M
Total Cash (Recent Filing)$452.57K
Total Debt (Recent Filing)$21.20M
Price to Earnings (P/E)―
Beta1.03
Next Earnings
May 19, 2025EPS Estimate
-0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.43
Shares Outstanding59,242,905
10 Day Avg. Volume122,708
30 Day Avg. Volume93,927
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-2.90
P/FCF Ratio0.00
Enterprise Value/Market Cap1.09
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-189.94
Enterprise Value/Ebitda-2.82
Forecast
1Y Price Target
$4.00Price Target Upside292.16% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
Bulls Say, Bears Say
Bulls Say
Clinical TrialsVivani announced the first subject has been implanted with NPM-115 in the Phase 1 LIBERATE-1 study, and the procedure was successful with no unexpected adverse events.
Preclinical DataVivani announced positive preclinical data for NPM-139, a subdermal semaglutide implant being developed for chronic weight management.
Strategic InitiativesVivani Medical plans to spin off Cortigent, Inc. as an independently operated, publicly traded company, allowing the two companies to pursue their respective strategic priorities and facilitate value creation.
Bears Say
Financial PerformanceNet loss totaled $6.0M in 3Q24, with cash flows from operating activities being negative $5.7M.
Funding ChallengesMore dilution may be required for future financing considering the current share price trading near a 52-week low and overall market dynamics.
Stock PriceThe 12-month price target is lowered to $4.00 from $8.00 due to dilution from the recent capital raise.
---
Ownership Overview
37.87% Insiders
2.17% Mutual Funds
4.86% Other Institutional Investors
53.41% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
VANI FAQ
What was Vivani Medical’s price range in the past 12 months?
Vivani Medical lowest stock price was $1.00 and its highest was $2.22 in the past 12 months.
What is Vivani Medical’s market cap?
Vivani Medical’s market cap is $62.20M.
When is Vivani Medical’s upcoming earnings report date?
Vivani Medical’s upcoming earnings report date is May 19, 2025 which is in 47 days.
How were Vivani Medical’s earnings last quarter?
Vivani Medical released its earnings results on Mar 31, 2025. The company reported -$0.11 earnings per share for the quarter, missing the consensus estimate of -$0.105 by -$0.005.
Is Vivani Medical overvalued?
According to Wall Street analysts Vivani Medical’s price is currently Undervalued.
Does Vivani Medical pay dividends?
Vivani Medical does not currently pay dividends.
What is Vivani Medical’s EPS estimate?
Vivani Medical’s EPS estimate is -0.1.
How many shares outstanding does Vivani Medical have?
Vivani Medical has 59,242,905 shares outstanding.
What happened to Vivani Medical’s price movement after its last earnings report?
Vivani Medical reported an EPS of -$0.11 in its last earnings report, missing expectations of -$0.105. Following the earnings report the stock price went down -5.405%.
Which hedge fund is a major shareholder of Vivani Medical?
Currently, no hedge funds are holding shares in VANI
---
Vivani Medical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.00 (292.16% Upside)
$4.00 (292.16% Upside)
Insider Transactions
Bought Shares
Worth $5.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 4.4%
Last 30 Days ▼ 4.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-48.48%
12-Months-Change
Fundamentals
Return on Equity
-122.42%
Trailing 12-Months
Asset Growth
-9.25%
Trailing 12-Months
Company Description
Vivani Medical
Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.
---
VANI Stock 12 Month Forecast
Average Price Target
$4.00
▲(292.16% Upside)
Technical Analysis
Best Analysts Covering VANI
1 Year
1 Year Success Rate
3/11 ratings generated profit
1 Year Average Return
-13.01%
reiterated a buy rating 2 days ago
Copying Naz Rahman's trades and holding each position for 1 Year would result in 27.27% of your transactions generating a profit, with an average return of -13.01% per trade.
---